-
FDA clears integration of OneTouch meter with WellDoc's diabetes management platform
CHESTERBROOK, Pa. — LifeScan, part of the Johnson & Johnson Diabetes Care Companies, earlier this week announced the U.S. Food and Drug Administration has cleared the wireless integration of the OneTouch Verio Flex blood glucose monitoring system with WellDoc's clinically validated diabetes management platform, BlueStar, creating a unique digital health solution for people living with Type 2 diabetes.
-
CHPA abuse efforts working: DXM abuse holds at 3%
WASHINGTON — The results of the 2016 National Institute on Drug Abuse and University of Michigan’s Monitoring the Future survey released earlier this week determined the percentage of teens using over-the-counter cough medicine containing dextromethorphan to get high remains at 3%.
When first reported by Monitoring the Future in 2006, teen OTC cough medicine abuse was at just under 6%.